Search results
While institutions own 23% of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), retail investors are...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Brainstorm Cell Therapeutics' significant retail investors ownership suggests that the...
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 months agoBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript November 14, 2023...
Brainstorm Cell Therapeutics Inc.'s (NASDAQ:BCLI) Path To Profitability
Simply Wall St. via Yahoo Finance· 7 months agoBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) is possibly approaching a major achievement in its...
FDA Refuses To Accept BrainStorm Cell's Lead Candidate For Amyotrophic Lateral Sclerosis
Benzinga via Yahoo Finance· 1 year agoBrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) received a refusal to file letter from the FDA...
Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 months agoParticipants Chaim Lebovits; President & CEO; Brainstorm Cell Therapeutics Inc. Stacy Lindborg; Co-CEO; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim CFO; Brainstorm Cell Therapeutics ...
The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – November 17, 2022 – Zacks.com announces the list of stocks...
Cathie Wood’s Latest Stock Picks: 11 Biggest Positions
Insider Monkey via Yahoo Finance· 3 months agoIn this piece, we will take a look at Cathie Wood’s latest stock picks and the 12 biggest positions...